One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis
- 17 June 2019
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 257 (9) , 1989-1996
Abstract
The aim of this study is to evaluate the clinical and immunological efficacy and safety of allergen immunotherapy (AIT) in patients with allergic conjunctivitis (AC) and to compare between sublingual and subcutaneous routes of administration.Keywords
This publication has 30 references indexed in Scilit:
- The skin prick test – European standardsClinical and Translational Allergy, 2013
- Allergic conjunctivitis: a comprehensive review of the literatureItalian Journal of Pediatrics, 2013
- Allergic conjunctivitis and the most common allergens in Northern GreeceWorld Allergy Organization Journal, 2013
- Recognition of allergic conjunctivitis in patients with allergic rhinitisWorld Allergy Organization Journal, 2013
- Efficacy of Sublingual Immunotherapy versus Subcutaneous Injection Immunotherapy in Allergic PatientsJournal of Environmental and Public Health, 2012
- Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitisCutaneous and Ocular Toxicology, 2010
- Achieving control of asthma in preschoolersCanadian Medical Association Journal, 2009
- Diagnosis and treatment of asthma in childhood: a PRACTALL consensus reportAllergy, 2007
- Comparison of Allergic Indices in Monosensitized and Polysensitized Patients with Childhood AsthmaJournal of Korean Medical Science, 2006
- Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: A 3-year randomized controlled studyJournal of Allergy and Clinical Immunology, 2005